Kevin Lobo

Chair and Chief Executive Officer, Stryker

About

Kevin Lobo is the Chair and Chief Executive Officer of Stryker, a medical technology company that offers products in MedSurg, Neurotechnology and Orthopaedics. He became CEO in October 2012 and chair of the board in July 2014. Stryker's 2026 proxy statement says his title changed to Chair and Chief Executive Officer on January 1, 2026, when the president title was no longer part of his role.

Lobo holds a Bachelor of Commerce from McGill University, an MBA from the University of Toronto and a Chartered Accountant qualification. He joined Stryker in 2011 as group president of Orthopaedics. Before Stryker he held leadership roles at Johnson & Johnson, including president of Ethicon Endo-Surgery. Other medical technology leaders on Whoo include Mike Mahoney of Boston Scientific and Robert Ford of Abbott.

Whoo compiled this page from public sources: Stryker leadership page, Stryker 2026 proxy statement (SEC), Stryker 2025 Form 10-K (SEC). It is not affiliated with or endorsed by Kevin Lobo. Are you Kevin Lobo? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17.

Want a page like this? Create yours from your résumé.

Experience

Chair and Chief Executive Officer — Stryker


2012 – Present

  • CEO since October 2012; chair since July 2014

  • Title changed to Chair and Chief Executive Officer on January 1, 2026
  • Group President, Orthopaedics — Stryker


    2011 – 2012

    Leadership roles — Johnson & Johnson

  • Included President of Ethicon Endo-Surgery

Education

MBA — University of Toronto

Bachelor of Commerce — McGill University

Chartered Accountant


Projects